Cdk2 Is Required for p53-Independent G2/M Checkpoint Control
Open Access
- 26 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 6 (2) , e1000863
Abstract
The activation of phase-specific cyclin-dependent kinases (Cdks) is associated with ordered cell cycle transitions. Among the mammalian Cdks, only Cdk1 is essential for somatic cell proliferation. Cdk1 can apparently substitute for Cdk2, Cdk4, and Cdk6, which are individually dispensable in mice. It is unclear if all functions of non-essential Cdks are fully redundant with Cdk1. Using a genetic approach, we show that Cdk2, the S-phase Cdk, uniquely controls the G2/M checkpoint that prevents cells with damaged DNA from initiating mitosis. CDK2-nullizygous human cells exposed to ionizing radiation failed to exclude Cdk1 from the nucleus and exhibited a marked defect in G2/M arrest that was unmasked by the disruption of P53. The DNA replication licensing protein Cdc6, which is normally stabilized by Cdk2, was physically associated with the checkpoint regulator ATR and was required for efficient ATR-Chk1-Cdc25A signaling. These findings demonstrate that Cdk2 maintains a balance of S-phase regulatory proteins and thereby coordinates subsequent p53-independent G2/M checkpoint activation. Metazoan cells contain multiple Cdks that regulate cell cycle progression. Recent studies have shown that mouse cells can grow normally with just Cdk1. The roles of the non-essential Cdks remain a fundamental question. In this study, we describe the generation and detailed characterization of CDK2-knockout human somatic cells. Our study demonstrates that Cdk2 is required for robust DNA damage checkpoint signaling. Loss of Cdk2 caused a marked deficiency in the G2/M arrest—a basic response to DNA damage—in cells that were also nullizygous for P53. We propose that the multiple Cdks present in metazoan cells provide a mechanism by which the cell cycle can be efficiently halted after DNA damage. Significantly, this study reveals a heretofore unrecognized dependence for Cdk2 in p53-deficient cancer cells.Keywords
This publication has 61 references indexed in Scilit:
- Functional genomic screens identify CINP as a genome maintenance proteinProceedings of the National Academy of Sciences, 2009
- Divergent S Phase Checkpoint Activation Arising from Prereplicative Complex Deficiency Controls Cell SurvivalMolecular Biology of the Cell, 2009
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- ATP-dependent activation of p21 WAF1/CIP1 -associated Cdk2 by Cdc6Proceedings of the National Academy of Sciences, 2008
- p21 Inhibits Cdk1 in the Absence of Cdk2 to Maintain the G1/S Phase DNA Damage CheckpointMolecular Biology of the Cell, 2008
- Cdk1 is sufficient to drive the mammalian cell cycleNature, 2007
- Specialized Roles of the Two Mitotic Cyclins in Somatic Cells: Cyclin A as an Activator of M Phase–promoting FactorMolecular Biology of the Cell, 2007
- Cdc18 Enforces Long-Term Maintenance of the S Phase Checkpoint by Anchoring the Rad3-Rad26 Complex to ChromatinMolecular Cell, 2007
- Cyclin A2 Regulates Nuclear-Envelope Breakdown and the Nuclear Accumulation of Cyclin B1Current Biology, 2007